ArticleClinical journal of the American Society of Nephrology : CJASN2013
The primary care perspective on routine urine dipstick screening to identify patients with albuminuria.
Article in Clinical journal of the American Society of Nephrology : CJASN, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Pediatric clinician perspectives on clinical decision support tools for chronic kidney disease risk after preterm birth.Pediatric nephrology (Berlin, Germany) · 2026Article
- Efficacy of screening with dipstick urinalysis in predicting renal function decline in healthy workers: a 10-year follow-up study.Clinical and experimental nephrology · 2025Article
- Mortality risk and years of life lost for people with reduced renal function detected from regular health checkup: A matched cohort study.Preventive medicine reports · 2023Article
- Analysis of Specialty Nephrology Care Among Patients With Chronic Kidney Disease and High Risk of Disease Progression.JAMA network open · 2022Article
- Impact of Kidney Failure Risk Prediction Clinical Decision Support on Monitoring and Referral in Primary Care Management of CKD: A Randomized Pragmatic Clinical Trial.Kidney medicine · 2022Article
- Chronic Kidney Disease Patients Visiting Various Hospital Departments: An Analysis in a Hospital in Central Tokyo, Japan.Journal of personalized medicine · 2022Article
- Kidney health for everyone everywhere-from prevention to detection and equitable access to care.Pediatric nephrology (Berlin, Germany) · 2020Article
- Dipstick proteinuria and cancer incidence: a nationwide population-based study.Journal of nephrology · 2020Article
- Impact of Postoperative Continuous Renal Replacement Therapy in Lung Transplant Recipients.Transplantation direct · 2020Article
- Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care.Kidney diseases (Basel, Switzerland) · 2020Article
- Kidney health for everyone everywhere: from prevention to detection and equitable access to care.Journal of nephrology · 2020Article
- A Systematic Review of Screening Tests for Chronic Kidney Disease: An Accuracy Analysis.Galen medical journal · 2020Review
- Kidney health for everyone everywhere - from prevention to detection and equitable access to care.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020Article
- Kidney Health for Everyone Everywhere: From Prevention to Detection and Equitable Access to Care.Canadian journal of kidney health and disease · 2020Article
- Is Dipstick Urinalysis Screening Beneficial in Men with Lower Urinary Tract Symptoms?Advances in therapy · 2019Observational
- Proteinuria Detected by Urine Dipstick Test as a Risk Factor for Atrial Fibrillation: A Nationwide Population-Based Study.Scientific reports · 2017Article
- APOL1 and APOL1-Associated Kidney Disease: A Common Disease, an Unusual Disease Gene - Proceedings of the Henry Shavelle Professorship.Glomerular diseasesReview
- Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care.Indian journal of nephrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proponents of routine urine dipstick screening to identify patients at risk for ESRD in the primary care setting have argued that urine dipsticks are inexpensive, low risk, acceptable to patients, and now, more accurate. Proponents believe that urine dipstick screening has the potential to improve outcomes for people with early disease and increase awareness of CKD. Most primary care physicians agree that populations who are at high risk for CKD should be tested and appropriately treated to decrease complications of ESRD. However, proponents of mass screening may not appreciate the challenges, limitations, and potential harms of screening. Urine dipstick testing does not meet all of the criteria for a good screening test. Screening the general population with urine dipsticks will generate many false positives--between 50% and 90% of positive tests--that will require follow-up, increase costs, and cause patient anxiety. Routine screening with urine dipsticks is not cost-effective on the order of $200,000 per quality-adjusted life year. Most importantly, there is little evidence that early identification of microalbuminuria in unselected patients influences outcomes of CKD. Without proof of effectiveness, overdiagnosis, a problem for even well established screening tests, is risked. Finally, no specialty society or preventive services group currently recommends general screening. Instead of screening, primary care physicians and nephrologists should work together to identify patients at high risk for ESRD and optimize management to improve outcomes for patients with CKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.